EssilorLuxottica × Ikerian AG
EssilorLuxottica announced the acquisition of Ikerian AG, a Swiss health-tech company operating under the brand RetinAI. [42, 49] The acquisition brings in RetinAI's platform, which uses AI and real-world data, including large-scale retinal images and biomarker datasets, to support diagnosis, monitor disease progression, and accelerate pharmaceutical clinical studies. [42, 43, 45] Financial terms of the transaction were not disclosed.
The asset
Acquisition of the health technology company operating as RetinAI and its AI-powered platform for collecting, processing, and analyzing large-scale retinal images, biomarker datasets, and real-world evidence.
The record
- Seller status
- Going concern
- Sector
- AI and data management in eyecare
- Modalities
- images, biomarkers, text
- Jurisdiction
- CH
What it means if you hold data
This acquisition shows a major player in vision care investing directly in AI and real-world data assets to create an integrated digital health ecosystem. It marks a strategic move beyond hardware and into data-driven services for diagnosis and monitoring.